These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3535448)

  • 21. Indirect immunoalkaline phosphatase staining of cytologic smears of serous effusions for tumor marker studies.
    To A; Dearnaley DP; Ormerod MG; Canti G; Coleman DV
    Acta Cytol; 1983; 27(2):109-13. PubMed ID: 6188304
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunohistochemical characterization of renal cell carcinomas].
    Bohle B; Waldherr R; Schwechheimer K; Moldenhauer G; Momburg F
    Verh Dtsch Ges Pathol; 1986; 70():274-8. PubMed ID: 3825252
    [No Abstract]   [Full Text] [Related]  

  • 23. Adrenal cortical adenoma and adrenal metastasis of renal cell carcinoma: immunohistochemical and DNA ploidy analysis.
    Kumar D; Kumar S
    Mod Pathol; 1993 Jan; 6(1):36-41. PubMed ID: 7678935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray.
    Abrahams NA; MacLennan GT; Khoury JD; Ormsby AH; Tamboli P; Doglioni C; Schumacher B; Tickoo SK
    Histopathology; 2004 Dec; 45(6):593-602. PubMed ID: 15569050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of lacto series type 2 antigens in human renal cell carcinoma and its clinical significance.
    Fukushi Y; Ohtani H; Orikasa S
    J Natl Cancer Inst; 1989 Mar; 81(5):352-8. PubMed ID: 2563403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-1 integrins in renal cell carcinoma--an immunohistochemical study.
    Heicappell R; Podlinski J; Mückshoff U; Buszello H; Ackermann R
    Investig Urol (Berl); 1994; 5():42-50. PubMed ID: 7719319
    [No Abstract]   [Full Text] [Related]  

  • 27. Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma.
    Chu P; Arber DA
    Am J Clin Pathol; 2000 Mar; 113(3):374-82. PubMed ID: 10705818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical significance of serum CA 19-9 in patients with gastric and colorectal carcinoma and immunohistochemical visualization of CA 19-9 in tumor tissues.
    Sekikawa K
    Fukushima J Med Sci; 1985 Jun; 31(1):29-42. PubMed ID: 3866740
    [No Abstract]   [Full Text] [Related]  

  • 29. Intermediate filament polypeptide patterns of renal cell carcinoma.
    Suzuki A; Umeda T; Moriyama N; Niijima T
    Cell Mol Biol; 1987; 33(4):495-506. PubMed ID: 2444339
    [No Abstract]   [Full Text] [Related]  

  • 30. Detection of tissue polypeptide antigen in salivary glands and salivary gland tumors. An immunohistochemical study.
    Caselitz J; Seifert G; Björklund B; Björklund V
    Appl Pathol; 1983; 1(2):115-20. PubMed ID: 6331474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tissue polypeptide antigen as a marker for prostatic neoplasms. Preliminary study].
    Ruibal A; Durán P; Ibarz L; Fraile M; Roca I; de Torres Mateos JA
    Arch Esp Urol; 1984; 37(5):399-403. PubMed ID: 6517625
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunofluorescent distribution of basement membrane components and intermediate filament proteins in 10 cases of renal cell carcinoma].
    Shen YY
    Zhonghua Bing Li Xue Za Zhi; 1988 Mar; 17(1):23-5. PubMed ID: 3042174
    [No Abstract]   [Full Text] [Related]  

  • 33. A study on the clinical usefulness of tissue polypeptide antigen in various blood diseases.
    Kageyama T; Oyabu H
    Bull Osaka Med Sch; 1983 Oct; 29(2):55-61. PubMed ID: 6680326
    [No Abstract]   [Full Text] [Related]  

  • 34. [Serum and tissue quantification of tissue polypeptide antigen (TPA) in transitional cell carcinoma of the bladder].
    Moreno Sierra J; Maestro de las Casas ML; Ortega Heredia MD; Blanco Jimenez E; Hermida Gutiérrez J; Resel Estévez L
    Arch Esp Urol; 1994 Dec; 47(10):979-84. PubMed ID: 7864679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clear cell carcinoma of the liver: a comparative immunohistochemical study with renal clear cell carcinoma.
    Murakata LA; Ishak KG; Nzeako UC
    Mod Pathol; 2000 Aug; 13(8):874-81. PubMed ID: 10955454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal tubular antigens in regenerative epithelium and renal carcinoma.
    Fleming S; Matthews TJ
    Br J Urol; 1987 Aug; 60(2):103-9. PubMed ID: 3311274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [CEA and TPA in serum and pleural exudates in patients with pulmonary neoplasms: preliminary results].
    Iannucci F; di Matteo L; Di Martino G; Tranchese D; Auriemma L; Micillo E; Catena E
    Arch Monaldi; 1983; 38(1-2):3-8. PubMed ID: 6675556
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical usefulness of serum TPA (tissue polypeptide antigen) in postsurgical diagnosis, prognosis and follow-up of lung cancer.
    Volpino P; Cangemi V; Caputo V; Graziani EP; Mazzarino E; Gentili S; Borghese M
    J Nucl Med Allied Sci; 1985; 29(3):241-4. PubMed ID: 4078636
    [No Abstract]   [Full Text] [Related]  

  • 39. CD70: a new tumor specific biomarker for renal cell carcinoma.
    Junker K; Hindermann W; von Eggeling F; Diegmann J; Haessler K; Schubert J
    J Urol; 2005 Jun; 173(6):2150-3. PubMed ID: 15879877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tissue polypeptide antigen (TPA) in liver tissue from patients with hepatocellular carcinoma].
    Onji M; Danjo K; Miyaoka H; Taniguchi Y; Ohta Y
    Nihon Shokakibyo Gakkai Zasshi; 1987 Nov; 84(11):2537-41. PubMed ID: 2831415
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.